These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25575286)

  • 1. Uncovering the evidence for behavioral interventions with individuals with fragile X syndrome: a systematic review.
    Moskowitz LJ; Jones EA
    Res Dev Disabil; 2015 Mar; 38():223-41. PubMed ID: 25575286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis and treatment of problem behavior exhibited by children with fragile X syndrome.
    Kurtz PF; Chin MD; Robinson AN; O'Connor JT; Hagopian LP
    Res Dev Disabil; 2015; 43-44():150-66. PubMed ID: 26183339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving social gaze behavior in fragile X syndrome using a behavioral skills training approach: a proof of concept study.
    Gannon CE; Britton TC; Wilkinson EH; Hall SS
    J Neurodev Disord; 2018 Aug; 10(1):25. PubMed ID: 30153790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parental reports on early language and motor milestones in fragile X syndrome with and without autism spectrum disorders.
    Hinton R; Budimirovic DB; Marschik PB; Talisa VB; Einspieler C; Gipson T; Johnston MV
    Dev Neurorehabil; 2013; 16(1):58-66. PubMed ID: 23249372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The behavioral phenotype of FMR1 mutations.
    Boyle L; Kaufmann WE
    Am J Med Genet C Semin Med Genet; 2010 Nov; 154C(4):469-76. PubMed ID: 20981777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive and behavioral correlates of caudate subregion shape variation in fragile X syndrome.
    Peng DX; Kelley RG; Quintin EM; Raman M; Thompson PM; Reiss AL
    Hum Brain Mapp; 2014 Jun; 35(6):2861-8. PubMed ID: 24038999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autism Symptoms in Fragile X Syndrome.
    Niu M; Han Y; Dy ABC; Du J; Jin H; Qin J; Zhang J; Li Q; Hagerman RJ
    J Child Neurol; 2017 Sep; 32(10):903-909. PubMed ID: 28617074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling fragile X syndrome in the laboratory setting: A behavioral perspective.
    Melancia F; Trezza V
    Behav Brain Res; 2018 Sep; 350():149-163. PubMed ID: 29704597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination disorders in persons with Prader-Willi and Fragile-X syndromes.
    Equit M; Piro-Hussong A; Niemczyk J; Curfs L; von Gontard A
    Neurourol Urodyn; 2013 Sep; 32(7):986-92. PubMed ID: 23239431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragile X syndrome: a review of clinical and molecular diagnoses.
    Ciaccio C; Fontana L; Milani D; Tabano S; Miozzo M; Esposito S
    Ital J Pediatr; 2017 Apr; 43(1):39. PubMed ID: 28420439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mobile technology use and skills among individuals with fragile X syndrome: implications for healthcare decision making.
    Raspa M; Fitzgerald T; Furberg RD; Wylie A; Moultrie R; DeRamus M; Wheeler AC; McCormack L
    J Intellect Disabil Res; 2018 Oct; 62(10):821-832. PubMed ID: 30105880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin as a Novel Interventional Candidate for Fragile X Syndrome with Autism Spectrum Disorder in Humans.
    Won J; Jin Y; Choi J; Park S; Lee TH; Lee SR; Chang KT; Hong Y
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How common are challenging behaviours amongst individuals with Fragile X Syndrome? A systematic review.
    Hardiman RL; McGill P
    Res Dev Disabil; 2018 May; 76():99-109. PubMed ID: 29525058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragile X syndrome: a review of associated medical problems.
    Kidd SA; Lachiewicz A; Barbouth D; Blitz RK; Delahunty C; McBrien D; Visootsak J; Berry-Kravis E
    Pediatrics; 2014 Nov; 134(5):995-1005. PubMed ID: 25287458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of mavoglurant and its potential for the treatment of fragile X syndrome.
    Gomez-Mancilla B; Berry-Kravis E; Hagerman R; von Raison F; Apostol G; Ufer M; Gasparini F; Jacquemont S
    Expert Opin Investig Drugs; 2014 Jan; 23(1):125-34. PubMed ID: 24251408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Providing a parent-implemented language intervention to a young male with fragile X syndrome: brief report.
    Oakes A; Ma M; McDuffie A; Machalicek W; Abbeduto L
    Dev Neurorehabil; 2015 Feb; 18(1):65-8. PubMed ID: 25325341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavior Problems and Social Competence in Fragile X Syndrome: A Systematic Review.
    Cregenzán-Royo O; Brun-Gasca C; Fornieles-Deu A
    Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral intervention for problem behavior in children with fragile X syndrome.
    Moskowitz LJ; Carr EG; Durand VM
    Am J Intellect Dev Disabil; 2011 Nov; 116(6):457-78. PubMed ID: 22126659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuroanatomy and neuroendocrinology of fragile X syndrome.
    Hessl D; Rivera SM; Reiss AL
    Ment Retard Dev Disabil Res Rev; 2004; 10(1):17-24. PubMed ID: 14994284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of ultrasonic vocalizations of Fragile X mice.
    Belagodu AP; Johnson AM; Galvez R
    Behav Brain Res; 2016 Sep; 310():76-83. PubMed ID: 27142239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.